Sarepta’s DMD Gene Therapy, Like Exondys 51, Is Foundational, Advocates Argue

 
• By Derrick Gingery
foundation
An approval of SRP-9001 will help other gene therapy improvements move forward, CureDuchenne's chief scientific officer said. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies